封面
市場調查報告書
商品編碼
1319991

腸外營養市場:依營養類型(胺基酸、碳水化合物、電解質)、按劑型(安瓿、袋、瓶)、最終用戶 - 全球預測 2023-2030

Parenteral Nutrition Market by Nutrient Type (Amino Acids, Carbohydrates, Electrolytes), Dosage Form (Ampules, Bags, Bottles), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球腸外營養市場預計將以8.64%的年複合成長率大幅成長,2023年達到76.7838億美元,到2030年將達到137.3572億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球腸外營養市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標,我們對供應商進行全面評估,使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限,並取得了不同程度的成功:前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻,可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解:

1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2. 市場開發:提供有關利潤豐厚的新興市場的詳細資訊,並分析其在成熟市場的滲透率。

3. 市場多元化:提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢:全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題:

1.全球腸外營養市場規模及預測為何?

2.在預測期內,COVID-19對全球腸外營養藥物市場的阻礙因素與影響為何?

3. 在預測期內,全球腸外營養市場需要投資哪些產品/細分市場/應用/領域?

4.全球腸外營養市場的競爭策略是什麼?

5. 全球腸外營養市場的技術趨勢和法律規範是什麼?

6.全球腸外營養市場主要供應商的市佔率為何?

7. 哪些型態和策略性措施被認為適合進入全球腸外營養市場?

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 腎臟病、肝病和癌症等慢性疾病的盛行率
      • 老年人口和營養不良人口比例增加
      • 世界各地的多胎出生率和早產
    • 抑制因素
      • 嚴格的政府法規對腸外營養核准
    • 機會
      • 創新的腸外和經腸營養治療
      • 腸外營養技術發展
    • 任務
      • 與腸外營養相關的複雜性
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 依營養類型分類的腸外營養市場

  • 胺基酸
  • 碳水化合物
  • 電解質
  • 脂質
  • 多種維生素配方和微量元素

第7章 依劑型分類的腸外營養市場

  • 安瓿
  • 包包
  • 瓶子
  • 小瓶

第8章 腸外營養市場:依最終用戶分類

  • 診所
  • 醫院
  • 長期照護提供者

第9章 美洲腸外營養市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太腸外營養市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲腸外營養市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析:主要企業
  • 競爭情境分析:主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-036C5CF3B54A

The Global Parenteral Nutrition Market is forecasted to grow significantly, with a projected USD 7,678.38 million in 2023 at a CAGR of 8.64% and expected to reach a staggering USD 13,735.72 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Parenteral Nutrition Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Parenteral Nutrition Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Nutrient Type, market is studied across Amino Acids, Carbohydrates, Electrolytes, Lipids, and Multivitamin Formulations & Trace Elements. The Electrolytes is projected to witness significant market share during forecast period.

Based on Dosage Form, market is studied across Ampules, Bags, Bottles, and Vials. The Vials is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Clinics, Hospitals, and Long-Term Care Providers. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Parenteral Nutrition Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Parenteral Nutrition Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Parenteral Nutrition Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Parenteral Nutrition Market?

4. What is the competitive strategic window for opportunities in the Global Parenteral Nutrition Market?

5. What are the technology trends and regulatory frameworks in the Global Parenteral Nutrition Market?

6. What is the market share of the leading vendors in the Global Parenteral Nutrition Market?

7. What modes and strategic moves are considered suitable for entering the Global Parenteral Nutrition Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Parenteral Nutrition Market, by Nutrient Type, 2022 vs 2030
  • 4.3. Parenteral Nutrition Market, by Dosage Form, 2022 vs 2030
  • 4.4. Parenteral Nutrition Market, by End-User, 2022 vs 2030
  • 4.5. Parenteral Nutrition Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
      • 5.1.1.2. Increasing rate of geriatric population and malnourished individuals
      • 5.1.1.3. High natality and premature births around the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Strict government rules regarding the approval of parenteral nutrition
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative parenteral and enteral nutrition therapy
      • 5.1.3.2. Technological developments in parenteral nutrition
    • 5.1.4. Challenges
      • 5.1.4.1. Associated complexities with parenteral nutrition
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Parenteral Nutrition Market, by Nutrient Type

  • 6.1. Introduction
  • 6.2. Amino Acids
  • 6.3. Carbohydrates
  • 6.4. Electrolytes
  • 6.5. Lipids
  • 6.6. Multivitamin Formulations & Trace Elements

7. Parenteral Nutrition Market, by Dosage Form

  • 7.1. Introduction
  • 7.2. Ampules
  • 7.3. Bags
  • 7.4. Bottles
  • 7.5. Vials

8. Parenteral Nutrition Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals
  • 8.4. Long-Term Care Providers

9. Americas Parenteral Nutrition Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Parenteral Nutrition Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Parenteral Nutrition Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PARENTERAL NUTRITION MARKET RESEARCH PROCESS
  • FIGURE 2. PARENTERAL NUTRITION MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PARENTERAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2022 VS 2030 (%)
  • FIGURE 5. PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2022 VS 2030 (%)
  • FIGURE 6. PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. PARENTERAL NUTRITION MARKET DYNAMICS
  • FIGURE 9. PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PARENTERAL NUTRITION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PARENTERAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. PARENTERAL NUTRITION MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PARENTERAL NUTRITION MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PARENTERAL NUTRITION MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PARENTERAL NUTRITION MARKET SIZE, BY LIPIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PARENTERAL NUTRITION MARKET SIZE, BY MULTIVITAMIN FORMULATIONS & TRACE ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 11. PARENTERAL NUTRITION MARKET SIZE, BY AMPULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PARENTERAL NUTRITION MARKET SIZE, BY BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PARENTERAL NUTRITION MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PARENTERAL NUTRITION MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. PARENTERAL NUTRITION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PARENTERAL NUTRITION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PARENTERAL NUTRITION MARKET SIZE, BY LONG-TERM CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 147. PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 148. PARENTERAL NUTRITION MARKET LICENSE & PRICING